65 i b, drugs, pharmaceuticals,&hematology related products, FSS contract award
Ended Awarded Last action
- Contract number
- 36F79718D0355
- Awardee
-
Alexion Pharmaceuticals Inc. UEI DKCXLGANZAN3
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 16
Award facts
- Opportunity
-
- 65IB Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $47,000,000.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
GSA issued a Federal Supply Schedule contract to Alexion Pharmaceuticals Inc. under the Pharmaceuticals and Drugs schedule (FSS-61-IB) on April 1, 2018, with a ceiling value of $47 million and ultimate completion date of June 15, 2026. The contract was legally cancelled and followed by a new award; the original contract ID is listed as 36F79726D0143.
Alexion, a Boston-headquartered biopharmaceutical company specializing in rare disease therapeutics, supplies specialized injectable medications to the Department of Veterans Affairs and its Veterans Integrated Service Networks (VISNs) nationwide. The company performs work from Boston, Massachusetts and Carrollton, Texas. All ordering activity under this schedule is firm fixed price with no set-aside designation.
Since the schedule's award, delivery orders have been issued across multiple VISNs for two primary products. Early orders (2018–2019) supplied Soliris (eculazumab), an injectable used to treat rare complement-mediated disorders, to VISNs 10 and regional VA medical centers in Michigan and Texas. From August 2022 forward, delivery orders have focused on Strensiq (80 mg/0.8 mL injectable), used to treat hypophosphatasia, a rare genetic disorder affecting pediatric and juvenile populations. Recent delivery orders include $1.26 million (awarded December 22, 2025, completion December 21, 2026), $626,866 (December 22, 2024), $522,487 (December 22, 2023), and $187,948 (November 3, 2023), all issued by VISN 20. Alexion also holds a single-award Blanket Purchase Agreement valued at $4.24 million, established September 1, 2022 and active through August 31, 2026, under the same Pharmaceuticals and Drugs schedule, enabling VISNs and individual VA facilities to place delivery orders as needed for Strensiq.
Task orders
Show all 16
IDV awards
| IDV | Agency | Ceiling | Awarded |
|---|---|---|---|
| 36E79722A0026 | National Acquisition Center (VA) | $4,239,518 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Show all 41
Quick answers
Who was awarded contract 36F79718D0355?
36F79718D0355 was awarded to Alexion Pharmaceuticals Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on April 1, 2018.
How much is contract 36F79718D0355 worth?
36F79718D0355's own ceiling is $47,000,000.
How many orders have been placed under contract 36F79718D0355?
16 orders have been placed under 36F79718D0355, the latest on July 21, 2026.
Who can order from contract 36F79718D0355?
36F79718D0355 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79718D0355 part of a contract vehicle?
Yes. 36F79718D0355 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79718D0355 competed?
The extent of competition for 36F79718D0355 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV